{"transactions":[{"id":905780,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:01:35.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":30000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-004166","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004166/rdgdoc.xml","form_type":"4"}},{"id":994375,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Common Stock","published_at":"2025-11-19T12:45:32.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":8.32,"value":20800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.26 to $8.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001437749-25-035653","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035653/rdgdoc.xml","form_type":"4"}},{"id":994374,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Common Stock","published_at":"2025-11-19T12:45:32.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":8.45,"value":8450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-25-035653","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035653/rdgdoc.xml","form_type":"4"}},{"id":1000764,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T13:52:19.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":7.44,"value":26040.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001437749-25-034639","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925034639/rdgdoc.xml","form_type":"4"}},{"id":1149722,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Common Stock","published_at":"2025-05-14T20:11:47.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":4233,"price":8.46,"value":35811.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average price of (i) 3,800 shares purchased at $8.4499 per share and (ii) 433 shares purchased at $8.5373 per share."}],"balance_after":5500,"source":{"system":"sec-edgar","filing":"0001437749-25-016843","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925016843/rdgdoc.xml","form_type":"4"}},{"id":1268012,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO & GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:02:02.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025."}],"balance_after":27000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001437749-25-004074","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925004074/rdgdoc.xml","form_type":"4"}},{"id":1422252,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO & GC"}}],"security":"Common Stock","published_at":"2024-08-27T20:09:50.000Z","date":"2024-08-27","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":18.16,"value":18160.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares purchased in open-market transactions."}],"balance_after":1267,"source":{"system":"sec-edgar","filing":"0001437749-24-027848","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924027848/rdgdoc.xml","form_type":"4"}},{"id":1669916,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:45:30.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":16000,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-24-002346","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002346/rdgdoc.xml","form_type":"4"}},{"id":1780415,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:51:10.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":16000,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-23-026070","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026070/rdgdoc.xml","form_type":"4"}},{"id":2295062,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Series C Convertible Preferred Stock","published_at":"2022-04-19T21:17:57.000Z","date":"2022-04-18","kind":"exercise","acquired":false,"shares":100,"price":25,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."}],"balance_after":0,"derivative":{"exercise_price":25,"underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001437749-22-009233","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922009233/rdgdoc.xml","form_type":"4"}},{"id":2295061,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Common Stock","published_at":"2022-04-19T21:17:57.000Z","date":"2022-04-18","kind":"exercise","acquired":true,"shares":100,"price":25,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001437749-22-009233","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922009233/rdgdoc.xml","form_type":"4"}},{"id":2322021,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Series C Convertible Preferred Stock","published_at":"2022-03-22T11:30:54.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":5000,"price":0.5,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"1.\tOn March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Shares\"), from the Issuer at a purchase price of $0.50 per Share in a private placement.  The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a \"Reverse Stock Split\") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a \"mirrored\" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.\tOn March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Shares\"), from the Issuer at a purchase price of $0.50 per Share in a private placement.  The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a \"Reverse Stock Split\") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a \"mirrored\" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1.\tOn March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Shares\"), from the Issuer at a purchase price of $0.50 per Share in a private placement.  The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a \"Reverse Stock Split\") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a \"mirrored\" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares."}],"balance_after":5000,"derivative":{"exercise_price":0.5,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-22-006872","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922006872/rdgdoc.xml","form_type":"4"}},{"id":2421399,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T11:04:46.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":305743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022."}],"balance_after":305743,"derivative":{"exercise_price":0.24,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":305743},"source":{"system":"sec-edgar","filing":"0001437749-22-001913","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922001913/rdgdoc.xml","form_type":"4"}},{"id":2809457,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T00:33:20.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":62522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The amount reported reflects the maximum number of shares of common stock underlying the award that may vest based upon the achievement of specified performance metrics. The vesting of such shares is contingent upon the timely and successful achievement during the year ending December 31, 2021 of certain performance milestones related to the Issuer's planned clinical trials, with the vesting of one-third (1/3) of the total shares tied to each such milestone. If any such milestone is achieved, one-third (1/3) of the shares tied to such milestone (i.e. one-ninth (1/9) of the total shares underlying the award) will vest immediately and the remainder of the shares tied to such milestone (i.e. two-ninths (2/9) of the total shares underlying the award) will vest in 24 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 24-month period commencing January 31, 2022. In order for all shares underlying the award to vest, all three milestones mus"}],"balance_after":62522,"derivative":{"exercise_price":1.11,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":62522},"source":{"system":"sec-edgar","filing":"0001437749-21-005059","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921005059/rdgdoc.xml","form_type":"4"}},{"id":2809456,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T00:33:20.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":87684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing March 31, 2021."}],"balance_after":87684,"derivative":{"exercise_price":1.11,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":87684},"source":{"system":"sec-edgar","filing":"0001437749-21-005059","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921005059/rdgdoc.xml","form_type":"4"}},{"id":2975867,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Common Stock","published_at":"2020-11-18T13:33:33.000Z","date":"2020-11-17","kind":"purchase","acquired":true,"shares":5000,"price":0.63,"value":3150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6234 to $0.6298, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001437749-20-024126","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920024126/rdgdoc.xml","form_type":"4"}},{"id":2975866,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Common Stock","published_at":"2020-11-18T13:33:33.000Z","date":"2020-11-16","kind":"purchase","acquired":true,"shares":10000,"price":0.67,"value":6700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6492 to $0.6890, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-20-024126","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920024126/rdgdoc.xml","form_type":"4"}},{"id":3007498,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-14T23:40:25.000Z","date":"2020-09-22","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"In connection with the Reporting Person's new employment with the Issuer, the Compensation Committee of the Issuer's Board of Directors approved the grant of non-qualified stock options to the Reporting Person.  The grant was made as an inducement material to the Reporting Person's acceptance of employment with the Issuer, in accordance with NASDAQ Listing Rule 5635(c)(4)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 36-month period beginning October 31, 2020."}],"balance_after":70000,"derivative":{"exercise_price":0.82,"expiration_date":"2030-09-22","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001437749-20-021143","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920021143/rdgdoc.xml","form_type":"4"}}]}